Google Übersetzer
Axim Biotechnologies, Inc.
About
0.01USD-0.00 -1.88%
Closed • Updated at 20:53 GMT+00:00Market Cap$1.96M
Volume125.9K
Beta1.30
RSI47.56
Axim Biotechnologies, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
Jan 29 2026
AXIM Biotechnologies, Inc. and Medical Marijuana, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
Jan 29 2026
Medical Marijuana, Inc. and AXIM Biotechnologies, Inc. Enter Into Strategic Alliance to Research and Develop Applications and Uses of Patent for Water Soluble Cannabinoids
Jan 20 2026
AXIM Biotechnologies Engages 624 Advisors, Owned and Managed by Dr. Alan J. Touch, Innovator and Global Regulatory Leader, as Chief Medical & Regulatory Affairs Advisor
Oct 23 2025
AXIM Biotechnologies, Inc. Announces Exclusive Distribution Agreement With VisionPlus Corp. for TearScan(R) Lactoferrin and IgE Diagnostic Tests in South Korea
Oct 7 2025
AXIM Biotechnologies Announces Exclusive Latin America License & Distribution Agreement With JK Medical for TearScan(R) Ocular Diagnostic Tests